Ron Paul
2007 Ron Paul Chapter 107

Ron Paul Two medical Breakthroughs From UTMB

12 December 2007

Home Page   Contents
Congressional Record   Cached

Not linked on Ron Paul’s Congressional website.
Two medical Breakthroughs From UTMB
12 December 2007

2007 Ron Paul 107:1
Mr. PAUL. Madam Speaker, researchers at the University of Texas Medical Branch (UTMB) have been responsible for two significant medical breakthroughs that have the potential to dramatically improve American health care.

2007 Ron Paul 107:2
Earlier this year, Dr. Lisa Elferink, an associate professor at UTMB’s Cancer Center, led a national research team that discovered how use of the bacterial pathogen, Listeria monocytogenes could help medical researchers and practitioners understand the mechanisms by which cancer cells develop. This discovery is a major step in developing successful treatments for a variety of cancers.

2007 Ron Paul 107:3
Another team of UTMB researchers, lead by Dr. Angela Shepherd, have helped American men at risk of osteoporosis by developing the Male Osteoporosis Risk Estimation Score (MORES). While osteoporosis screening is common for women, many men who are at risk for this bone disease are not regularly checked. MORES provides a quick and easy way to identify men who may need further screening and possibly treatment for osteoporosis.

2007 Ron Paul 107:4
The development of MORES and the new use of Listeria monocytogenes are just two of the advances in medical research to come out of UTMB. UTMB is one of America’s leading centers of medical research, as well as a source of quality health care for the people of the Gulf Coast of Texas. Madam Speaker, it gives me great pleasure to extend my congratulations to the researchers involved in these recent breakthroughs and to everyone associated with UTMB for their tireless work to improve health care.

Previous   Next

Home Page   Contents   Concordance   Links